CD BioGlyco Launches Anti-glycan Antibody Development Services to Advance Biomedical Research

CD BioGlyco, a leader in the field of glycobiology, today announced the launch of its anti-glycan antibody development service. The new service provides researchers with a comprehensive solution for developing high-quality, specific, and sensitive anti-glycan antibodies.   Anti-glycan antibodies are necessary for locating glycans, tracking their expression, and identifying the biological effects they have. They…

Read More